Six young adult male rhesus monkeys were given diethylnitrosamine ip for 3-5 years. Liver biospies were done monthly. After 6 months, biopsy specimens showed individual hepatocytes and small foci of hepatocytes that were intensely positive for glycogen. During the second and later years, larger foci of such cells developed. In sections stained with hematoxylin and eosin, the glycogen-containing hepatocytes generally appeared unusually clear. Some hepatocytes, however, had eosinophilic or basophilic cytoplasm. Nuclear enlargement and atypic developed, particularly outside the foci. The hepatocytes within most foci were uniform in their histochemical features: glycogen was elevated, glucose-6-phosphatase was decreased, and ATPase activity was present not only along the bile canalicular surface but also along the enire cell membrane. After 3-5 years, neoplastic nodules and hepatocarcinomas developed in 5 of 6 animals. Two nodules and particularly the heptocarcinomas differed from the foci in one of more histochemical parameters. The findings suggested that the glycogen-containing, histochemically altered cells of the foci in one or more histochemical parameters. The findings suggested that the glycogen-containing, histochemically altered cells of the foci may be the first step in the development of neoplasia; further steps toward malignancy appeared to be frequently associated with additional alterations, such as loss of sinusoidal ATPase and re-formation of glucose-6-phosphatase.
Bacal NS et al Rev. bras. hematol. hemoter. 2005;27(1):31-36 Artigo / Article Mieloma Múltiplo: 50 casos diagnosticados por citometria de fluxo Multiple Myeloma: 50 cases diagnosed by flow cytometry O Mieloma Mútiplo é uma doença de evolução heterogênea, na qual a maioria dos pacientes recai muito precocemente após o tratamento. Nesse contexto, o objetivo principal deste trabalho é relatar diferentes estratégias de análise do mieloma por citometria de fluxo e sua importância na associação com citogenética no diagnóstico de doença residual. Entre 2.450 casos de doenças onco-hematológicas estudados, de setembro de 1993 a agosto de 2004, foram diagnosticados 50 (2,0%) Mieloma Múltiplo. Foram feitas análises morfológicas e, até o ano de 2000, as imunofenotipagens foram realizadas no citômetro de fluxo XL-MCL (Coulter) pela estratégia tamanho/ complexidade, utilizando os anticorpos monoclonais CD19, CD20, CD38, CD45, CD56, HLA-DR, kappa e lambda de superfície e intracitoplasmáticas. A partir de 2001 passaram-se a utilizar painéis seqüenciais através do histograma CD138/ Complexidade e anticorpos monoclonais CD19, CD38, CD56, CD117, kappa e lambda intracitoplasmáticas. Mais recentemente foram incluídos no painel os anticorpos CD45, HLA-DR e CD33. A análise do DNA foi realizada por citometria com auxílio do programa Multicycle em nove amostras, sendo que sete apresentaram população aneuplóide. O cariótipo com banda G foi realizado em 25 casos, e a pesquisa de deleção do 13q por FISH em 15. Alterações cromossômicas foram encontradas em 4 casos, sendo duas deleções de 13q confirmadas por FISH. A mudança na estratégia de gates associada à citogenética e ao estudo da cinética do ciclo do DNA permitem melhor identificação de células plasmáticas anômalas, avaliação do prognóstico e detecção de doença residual. Rev. bras. hematol. hemoter. 2005;27(1):31-36. Palavras-chave: Mieloma Múltiplo; citometria de fluxo; citogenética; doença residual. Rev. bras. hematol. hemoter. 2005;27(1):31-36 Bacal NS et al kinetics of DNA are all data that permit better identification of anomalous plasma cells and therefore detection of minimal residual disease, that probably correlates with relapse prognosis. Rev. bras. hematol. hemoter. 2005;27(1):31-36.
BackgroundCancer development results from the progressive accumulation of genomic abnormalities that culminate in the neoplastic phenotype. Cytogenetic alterations, mutations and rearrangements may be considered as molecular legacy which trace the clonal history of the disease. Concomitant tumors are reported and they may derive from a common or divergent founder clone. B-cell chronic lymphocytic leukemia (B-CLL) and plasma cell myeloma (PCM) are both mature B-cell neoplasms, and their concomitancy, albeit rare, is documented.Case presentationHere, we described a patient with prior B-CLL with secondary development of PCM. Cytogenetic and multi parametric flow cytometry analyses were performed. The B-CLL population presented chromosome 12 trisomy, unlikely the arisen PCM population.ConclusionThe close follow up of B-CLL patients is important for early intervention in case of development of other malignancy, such as myeloma. Our observation suggests these two diseases may have arisen from different clones. We understand that the investigation of clonal origin may provide important information regarding therapeutic decisions, and should be considered in concomitant neoplasm.
Flow cytometry adds to the results of morphologic and immunohistochemical studies, facilitating a rapid and accurate diagnosis of lymphoproliferative diseases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.